Company profile · Jelgava District, Latvia

PrintyMed

Biomimetic Spider Silk, Biomaterial Scaffolds, Organ-on-a-Chip Membranes, and Regenerative Medicine Components · Early-stage biomaterials and scaffold-development platform

LatviaBiotechJelgava District

PrintyMed runs biomimetic spider-silk material development, regenerative scaffold design, and organ-on-a-chip membrane prototyping in Jelgava District, Latvia.

Lead
Jekaterina Romanova (verified ↗)
Address
Tomini, Cenu pag., Jelgavas nov., LV-3018, Latvia (source ↗)
Compliance
Not yet on record
Last reviewed
21 Mar 2026 (2mo ago)
Scale
Early-stage biomaterials and scaffold-development platform
Capabilities
Biomimetic Spider-Silk Material Development · Regenerative Scaffold Design · Organ-on-a-Chip Membrane Prototyping
Founded
2018
Headcount
1-10
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Jekaterina Romanova

CEO

Check official leadership source
Full addressTomini, Cenu pag., Jelgavas nov., LV-3018, Latvia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Business.gov.lv company profile listing the legal address of SIA PrintyMed in Cenu pagasts, Jelgava municipality.

Open source
Operating profile

Early-stage biomaterials and scaffold-development platform

Jelgava District, Latvia. Biomimetic Spider Silk, Biomaterial Scaffolds, Organ-on-a-Chip Membranes, and Regenerative Medicine Components. Review completed on 21 Mar 2026.

2026 technical specializationBiomimetic Spider Silk, Biomaterial Scaffolds, Organ-on-a-Chip Membranes, and Regenerative Medicine Components
Core capabilities
Biomimetic Spider-Silk Material DevelopmentRegenerative Scaffold DesignOrgan-on-a-Chip Membrane Prototyping
Governance

Latvian commercial-register oversight and early-stage biotech company governance

Business.gov.lv company profile for SIA PrintyMed, Registered company number 40203456040, Latvian chemical, pharma, and biotechnology sector classification

Editorial note

Biomimetic Spider Silk, Biomaterial Scaffolds, Organ-on-a-Chip Membranes, and Regenerative Medicine Components

PrintyMed is published because the official site identifies the current chief executive and clearly presents a life-science biomaterials platform, while the Latvian business profile confirms the legal entity and biotech-sector registration.

Editorial note

PrintyMed is published because the official site identifies the current chief executive and clearly presents a life-science biomaterials platform, while the Latvian business profile confirms the legal entity and biotech-sector registration.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 21 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Biomimetic Spider-Silk Material Development
Regenerative Scaffold Design
Organ-on-a-Chip Membrane Prototyping
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial PrintyMed homepage naming Jekaterina Romanova as CEO in the founding team section.Source origin: printymed.comOpen source
Supporting evidenceOfficial PrintyMed homepage describing the company's biomimetic spider-silk platform for organ-on-a-chip membranes, regenerative wound dressings, heart-valve prostheses, and artificial-organ scaffolds.Source origin: printymed.comOpen source
Physical-site evidenceBusiness.gov.lv company profile listing the legal address of SIA PrintyMed in Cenu pagasts, Jelgava municipality.Source origin: business.gov.lvOpen source
Infrastructure

Declared infrastructure

Biomaterial membrane prototyping workflow
Spider-silk-inspired material development
Regenerative scaffold design systems
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is PrintyMed located?
PrintyMed operates from Tomini, Cenu pag., Jelgavas nov., LV-3018, Latvia, Jelgava District, Latvia.
Who runs PrintyMed?
PrintyMed is led by Jekaterina Romanova, CEO. Verified 21 Mar 2026.
What does PrintyMed do?
PrintyMed runs biomimetic spider-silk material development, regenerative scaffold design, and organ-on-a-chip membrane prototyping in Jelgava District, Latvia. Core capabilities: Biomimetic Spider-Silk Material Development, Regenerative Scaffold Design, Organ-on-a-Chip Membrane Prototyping.
Editorial context

Related technical briefs

Briefs that name Jelgava District as a covered market or city.